Status:
COMPLETED
The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease
Lead Sponsor:
Baker Heart Research Institute
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
Up to 70 years
Phase:
PHASE4
Brief Summary
One important clinical challenge in older individuals is maintaining mobility in the absence of pain. Peripheral arterial disease affects up to 12% of adults over 50 and impairs quality of life due to...
Eligibility Criteria
Inclusion
- Ankle-brachial index of \<0.9 at rest in at least one leg
- History of intermittent claudication (unilateral or bilateral) which was stable for 6 months
- Evidence of superficial femoral artery stenosis or occlusion on duplex scan
- Blood pressure \<=160/90 mmHg
- Stable medication regimen for at least 6 months and not previously treated with ACE inhibitors
Exclusion
- Limiting coronary artery disease
- Renal Failure
- History of hypertension
- History of type 2 diabetes mellitus
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00168467
Last Update
January 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3004